KDEVF (KDventures AB) 1-Year Sharpe Ratio: -55.54 (As of Jun. 29, 2026)


KDEVF KDventures AB KDEVF
30 GF Score
Price $0.26
GF Value $0.67
! 3 Warning Signs
View Full Analysis

What is KDventures AB 1-Year Sharpe Ratio?

KDventures AB KDEVF 30 1-Year Sharpe Ratio is -55.54 as of Jun. 29, 2026. GuruFocus rates KDEVF with a GF Score™ of 30/100 and a GF Value™ of $0.67. The stock has 3 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-06-29), KDventures AB's 1-Year Sharpe Ratio is -55.54.

KDventures AB  (OTCPK:KDEVF) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

KDventures AB 1-Year Sharpe Ratio Related Terms

KDEVF vs VRTX, REGN, ALNY: 1-Year Sharpe Ratio Comparison

For the Biotechnology subindustry, KDventures AB's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

KDventures AB 1-Year Sharpe Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, KDventures AB's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where KDventures AB's 1-Year Sharpe Ratio falls into.


KDEVF
30GF Score
KDventures AB KDEVF
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

KDventures AB 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of -55.54 mean?
KDventures AB (KDEVF) has a 1-Year Sharpe Ratio of -55.54 as of Jun. 29, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for KDventures AB and its competitors.
Is KDventures AB's 1-Year Sharpe Ratio too high?
KDventures AB's current 1-Year Sharpe Ratio is -55.54. Overall, KDventures AB has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does KDventures AB's 1-Year Sharpe Ratio compare to VRTX and REGN?
KDventures AB's 1-Year Sharpe Ratio of -55.54 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Biotechnology company?
A good 1-Year Sharpe Ratio depends on the Biotechnology industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for KDventures AB and its competitors. KDventures AB's current 1-Year Sharpe Ratio is -55.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KDventures AB stock overvalued right now?
KDventures AB (KDEVF) has a current 1-Year Sharpe Ratio of -55.54. The stock's GF Value™ is $0.67, compared to a current price of $0.26 — trading 61.6% below its estimated fair value. The current 1-Year Sharpe Ratio is -55.54. KDventures AB's overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For KDventures AB (KDEVF), the current 1-Year Sharpe Ratio is -55.54 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is KDventures AB (KDEVF) Overvalued in 2026?

Based on GuruFocus' analysis, KDventures AB stock appears to be undervalued. The current stock price of $0.26 is trading 61.6% below its estimated GF Value™ of $0.67.

Key valuation signals for KDEVF:

  • 1-Year Sharpe Ratio: -55.54
  • GF Value™: $0.67 vs. price of $0.26 (61.6% below fair value)
  • GF Score™: 30/100 with 3 warning signs

No single metric tells the full story. See the KDEVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

KDventures AB Business Description

Address Nanna Svartz vag 6A, Solna, SWE, 171 65
KDventures AB is a Nordic investment company specialized in life sciences. The company identifies and invests in pharmaceutical projects and medical technology products originating from research institutions in the Nordic region. Through a diversified portfolio across various stages of development, professional due diligence, and active board engagement, the company creates value from early research to commercialization. The company offers investors exposure to both listed and private life science projects with value growth potential.
30GF Score

Get the complete analysis for KDEVF

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.26
Price
$0.67
GF Value